Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Viemed Healthcare, Inc.

Filed: Jun 4, 2026CIK: 0001729149
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Viemed Healthcare shareholders approved a Second Amendment to the 2024 Long Term Incentive Plan on June 4, 2026, increasing the maximum shares reserved for issuance to 7,696,717 shares. This expansion of the equity compensation pool signals the company's commitment to enhanced incentive structures and broader equity participation among key personnel.

Key Takeaways

Total shares reserved under the 2024 LTIP increased to 7,696,717, with a maximum of 1,000,000 shares available as incentive stock options

The Second Amendment was previously approved by the Board of Directors on April 7, 2026, and received shareholder approval on June 4, 2026

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 4, 2026
Item5.02
CategoryExecutive Change
CIK0001729149
Accession #vmd-20260604
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offering

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings